Rakovina Therapeutics Inc (RKV) — Cash Flow-to-Debt Ratio
Latest as of September 2025:
-0.31x
Rakovina Therapeutics Inc (RKV) has a Cash Flow-to-Debt Ratio of -0.31x as of September 2025, meaning its operating cash flow of CA$-1.04 Million could theoretically repay 0% of its total liabilities (CA$3.38 Million) in one year. See RKV FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.31x
Operating CF / Total Liabilities
Operating Cash Flow
CA$-1.04 Million
CAD
Total Liabilities
CA$3.38 Million
CAD
Data as of
Sep 2025
Most recent filing
Rakovina Therapeutics Inc Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for Rakovina Therapeutics Inc across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does Rakovina Therapeutics Inc generate cash.
Annual Cash Flow-to-Debt Ratio for Rakovina Therapeutics Inc (2021–2024)
Year-by-year debt coverage analysis for Rakovina Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.99x | CA$-3.86 Million | CA$1.94 Million | ▼ -58.6% |
| 2023 | -1.25x | CA$-1.86 Million | CA$1.49 Million | ▲ +93.0% |
| 2022 | -17.91x | CA$-1.92 Million | CA$107.05K | ▲ +11.6% |
| 2021 | -20.25x | CA$-2.31 Million | CA$113.98K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.